Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05856136 · ClinicalTrials.gov registry record · Phase 4
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
A Phase 4 study of Respiratory Complication and Respiratory Function Loss, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT05856136 is a Phase 4 study of Respiratory Complication and Respiratory Function Loss that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 69 participants, below the 120-participant average among 3 other Respiratory Complication trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05856136, a Phase 4 study of Respiratory Complication and Respiratory Function Loss, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate opioid dose effects on the ability of the diaphragm muscle to generate higher force behaviors.
Conditions Studied
Interventions
- DRUG Fentanyl Injection
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05856136
The ClinicalTrials.gov registry entry for NCT05856136 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 120-participant average among 3 other Respiratory Complication trials with a reported enrollment target (42% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Respiratory Complication appearing as the primary indexed condition, and to 1 intervention - of which Fentanyl Injection is the first listed.
NCT05856136 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05856136 about?
NCT05856136 is a clinical study titled "A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle". The purpose of this study is to evaluate opioid dose effects on the ability of the diaphragm muscle to generate higher force behaviors.
What is the current status of trial NCT05856136?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2023-06-19. Estimated completion is 2026-06-01.
What conditions does trial NCT05856136 study?
This clinical trial studies the following conditions: Respiratory Complication, Respiratory Function Loss.
What interventions are being tested in trial NCT05856136?
The interventions under investigation include: Fentanyl Injection (DRUG).
Who is sponsoring clinical trial NCT05856136?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05856136 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.